Rockefeller Capital Management L.P. Alector, Inc. Transaction History

Rockefeller Capital Management L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 06, 2023	SELL	$6.88 - $9.55 $11,696 - $16,235	-1,700 Reduced 62.5%	1,020 $9,000
Q3 2022 Nov 02, 2022	SELL	$8.19 - $13.2 $3,865 - $6,230	-472 Reduced 14.79%	2,720 $25,000
Q2 2022 Aug 12, 2022	BUY	$7.65 - $14.24 $3,618 - $6,735	473 Added 17.4%	3,192 $32,000
Q1 2022 May 13, 2022	SELL	$13.02 - $20.78 $3,906 - $6,234	-300 Reduced 9.94%	2,719 $38,000
Q4 2021 Feb 14, 2022	BUY	$19.35 - $25.54 $290 - $383	15 Added 0.5%	3,019 $62,000
Q3 2021 Nov 12, 2021	BUY	$21.65 - $39.49 $21,736 - $39,647	1,004 Added 50.2%	3,004 $68,000
Q2 2021 Aug 10, 2021	BUY	$15.5 - $22.48 $10,850 - $15,736	700 Added 53.85%	2,000 $41,000
Q1 2021 May 11, 2021	SELL	$14.84 - $22.23 $6,143 - $9,203	-414 Reduced 24.15%	1,300 $26,000
Q4 2020 Feb 12, 2021	BUY	$9.4 - $16.7 $470 - $835	50 Added 3.0%	1,714 $25,000
Q3 2020 Nov 13, 2020	BUY	$10.54 - $24.96 $17,538 - $41,533	1,664 New	1,664 $17,000

168

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $135M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.